廣告
香港股市 將在 20 分鐘 開市

  • 恒指

    17,201.27
    +372.34 (+2.21%)
     

  • 國指

    6,100.22
    +145.60 (+2.45%)
     

  • 上證綜指

    3,044.82
    +22.84 (+0.76%)
     

  • 道指

    38,460.92
    -42.77 (-0.11%)
     

  • 標普 500

    5,071.63
    +1.08 (+0.02%)
     

  • 納指

    15,712.75
    +16.11 (+0.10%)
     

  • Vix指數

    15.97
    +0.28 (+1.78%)
     

  • 富時100

    8,040.38
    -4.43 (-0.06%)
     

  • 紐約期油

    82.67
    -0.14 (-0.17%)
     

  • 金價

    2,331.00
    -7.40 (-0.32%)
     

  • 美元

    7.8288
    -0.0021 (-0.03%)
     

  • 人民幣

    0.9247
    0.0000 (0.00%)
     

  • 日圓

    0.0501
    -0.0001 (-0.12%)
     

  • 歐元

    8.3774
    +0.0017 (+0.02%)
     

  • Bitcoin

    64,603.07
    -2,209.14 (-3.31%)
     

  • CMC Crypto 200

    1,394.16
    -29.94 (-2.10%)
     

Leidos Bags $53M Task Order For Warfighter Performance Research

Akanksha Bakshi
·1 分鐘文章

  • Leidos Holdings Inc (NYSE: LDOS) has secured a new task order from Naval Medical Readiness Logistics Command, Detachment Fort Detrick, formerly Naval Medical Logistics Command.

  • The contract value totals ~$53 million and include a one-year base period of performance with four one-year options and one six-month option.

  • The single award, IDIQ task order, will support research to maximize warfighter performance and survivability in aviation, underwater and special warfare environments.

  • Leidos will support research on the human cognitive and physiological factors associated with military operations in aviation, space, underwater, and special warfare environments.

  • Leidos will provide technical support through the collection and analysis of data, computer programming, statistical analysis, and scientific reporting.

  • Price Action: LDOS shares are trading higher by 0.03% at $103.54 on the last check Wednesday.

See more from Benzinga

廣告

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.